Access cutting-edge non-hodgkin lymphoma treatment through this clinical trial at a research site in Stony Brook. Study-provided care at no cost to qualified participants.
Access non-hodgkin lymphoma specialists in Stony Brook at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-hodgkin lymphoma treatment provided free
This study is researching an experimental drug called odronextamab (referred to as study drug), in combination with lenalidomide. The study is focused on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back after treatment (called "relapsed"), or did not respond to treatment (called "refractory"). FL and MZL are subtypes of Non-Hodgkin 's lymphoma (NHL). This study will be made up of two parts (Part 1 not randomized, Part
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this non-hodgkin lymphoma clinical trial in Stony Brook, NY
If you're searching for non-hodgkin lymphoma treatment options in Stony Brook, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stony Brook research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.